Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioLineRx Ltd. - American Depositary Shares (NQ:BLRX)

2.180 UNCHANGED
Streaming Delayed Price Updated: 3:58 PM EDT, Apr 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BioLineRx Ltd. - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
S&P 500 Gains 1%; Fastenal Posts Downbeat Earnings ↗
 
Via Benzinga
Topics Stocks
News headline image
Dow Jumps Over 300 Points; US Industrial Production Beats Estimates ↗
 
Via Benzinga
Topics Stocks
News headline image
Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Earnings Preview For BioLine Rx ↗
 
Via Benzinga
News headline image
BLRX Stock Earnings: BioLine Rx Beats Revenue for Q2 2024 ↗
BLRX stock results show that BioLine Rx beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Earnings Preview For BioLine Rx ↗
 
Via Benzinga
News headline image
BioLine Rx Earnings Preview ↗
 
Via Benzinga
News headline image
Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet ↗
 
Via Benzinga
News headline image
S&P Jumps 1%; Regional Health Properties Shares Spike Higher ↗
 
Via Benzinga
Topics Stocks
News headline image
US Stocks Open Higher; Dow Jumps Over 200 Points ↗
 
Via Benzinga
Topics Stocks
News headline image
Why Check-Cap Shares Are Trading Higher By Over 52%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 25, 2024 ↗
 
Via Benzinga
News headline image
HC Wainwright & Co. Maintains Buy Rating for BioLine Rx: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Why Arcadium Lithium Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Tuesday morning! 
Via InvestorPlace
News headline image
Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025 ↗
These 10X penny stocks have the potential to mint millionaires with enough capital but buy wisely as the risk is real. 
Via InvestorPlace
News headline image
BLRX Stock Earnings: BioLine Rx Beats EPS for Q1 2024 ↗
BLRX stock results show that BioLine Rx beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
BLRX Stock Earnings: BioLine Rx Beats EPS for Q4 2023 ↗
BLRX stock results show that BioLine Rx beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market – A Race Worth
EQNX::TICKER_START (ONASDAQ:ONCY),(TSX:ONC),(NASDAQ:BLRX),(NASDAQ:IMRX),(NASDAQ:CADL) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Earnings Scheduled For March 26, 2024 ↗
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million. 
Via Benzinga
News headline image
3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond ↗
When you want to light your afterburners, these ideas will do the trick. 
Via InvestorPlace
News headline image
Earnings Scheduled For November 20, 2023 ↗
Companies Reporting Before The Bell • Greenland Technologies (NASDAQ:GTEC) is projected to report quarterly earnings at $0.05 per share on revenue of $24.26 million. 
Via Benzinga
News headline image
Week In Review: Hengrui Out-Licenses Next-Gen PARP1 To Merck KGaA For $1.7 Billion ↗
Jiangsu Hengrui Pharma out-licensed global rights for its next-gen PARP1 inhibitor to Germany’s Merck KGaA for a $170 million upfront payment and up to $1.5 billion in milestones. Merck will have... 
Via Talk Markets
News headline image
3 Tech Stocks That Wall Street Loves More Than Nvidia ↗
Purchase these top tech stocks now to achieve maximum profits and allow your portfolio to skyrocket given the volatile market. 
Via InvestorPlace
News headline image
3 Top Penny Stocks to Make You a Millionaire in 5 Years ↗
Penny stocks can make you a millionaire with patience and luck especially when you follow secular trends overall. 
Via InvestorPlace
News headline image
BioLineRx Touts Encouraging Data From Therapy Trial For First Line Pancreatic Cancer ↗
BioLineRx Ltd (NASDAQ: BLRX) announced data from the single-arm pilot phase of the investigator-initiated CheMo4METPANC Phase 2 combination trial of motixafortide and gemcitabine and nab-paclitaxel... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.